1. BaxΔ2 sensitizes colorectal cancer cells to proteasome inhibitor-induced cell death
   Adriana Mañas et al, 2018, Biochemical and Biophysical Research Communications CrossRef
2. LINC00461 Knockdown Enhances the Effect of Ixazomib in Multiple Myeloma Cells
   Mingyang Deng et al, 2023, Current Cancer Drug Targets CrossRef
3. Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor
   Neeraj Gupta et al, 2019, Clinical Pharmacokinetics CrossRef
4. Revisiting Proteasome Inhibitors: Molecular Underpinnings of Their Development, Mechanisms of Resistance and Strategies to Overcome Anti-Cancer Drug Resistance
   Carlota Leonardo-Sousa et al, 2022, Molecules CrossRef
5. An evolutionarily conserved ubiquitin ligase drives infection and transmission of flaviviruses
   Linjuan Wu et al, 2024, Proceedings of the National Academy of Sciences CrossRef
6. Principles of Drug Metabolism and Interactions in Cardio‐Oncology
   SHERRY‐ANN BROWN et al, 2022, Drug Metabolism Handbook CrossRef
7. Interactions between cardiology and oncology drugs in precision cardio-oncology
   Sailaja Kamaraju et al, 2021, Clinical Science CrossRef